United Neuroscience

📍 Dublin, Ireland🗓 Founded 2014👥 7 employees💰 Last funded Oct 2019
United Neuroscience (UNS) is a clinical stage biotech company dedicated to the development of best-in-class therapies for the brain. We are pioneering a new class of medicine we call endobody vaccines based on our proprietary, commercially proven platform technologies to treat and prevent Alzheimer’s and other neurological disorders. We have built a robust translational platform to rapidly design and develop targeted immunotherapeutics leveraging the industry’s leading endobody vaccine technology. Our proprietary platform technologies have successfully commercialized over 3 billion doses to date in multiple indications and launched 1 of only a handful of licensed vaccines against an endogenous host protein in the world. We are not afraid to be brave and tackle the seemingly impossible. We are committed to transforming the lives of patients and families affected by Alzheimer’s, Parkinson’s, ALS and other neurological diseases. We envision a world where the incidence of Alzheimer’s is cut in half by 2050 and where neurodegenerative diseases are prophylactically eradicated from the world.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2014
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in United Neuroscience?
United Neuroscience has 2 investors on record on gritt.io, 2 mid-stage.
When did United Neuroscience last raise funding?
The most recent investment in United Neuroscience recorded on gritt.io was in October 2019.
When was United Neuroscience founded?
United Neuroscience was founded in 2014.
What industry is United Neuroscience in?
United Neuroscience operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is United Neuroscience based?
United Neuroscience is headquartered in Dublin, Ireland.